Friday, 16 October 2026European Markets

Euro Surges 14% Against Dollar as Sterling Drops to €1.13 Two-Year Low

The euro appreciated 14% in 2025 while the U.S. Dollar Index tumbled 10.8% in early 2026, driving major currency realignment across European markets. The British pound fell 0.4% to €1.13—its lowest level since April 2023—despite gaining 7% against the dollar in 2025, as analysts warn of further pressure toward $1.30.

LM Salvado
LM Salvado

March 17, 2026

Euro Surges 14% Against Dollar as Sterling Drops to €1.13 Two-Year Low
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.
Loading stream...

The euro gained 14% against the dollar in 2025, marking a significant shift in European currency dynamics as the U.S. Dollar Index dropped 10.8% in early 2026.1 The broad-based dollar weakness has created divergent outcomes for European currencies, with the British pound facing renewed pressure despite earlier strength.

Sterling fell 0.4% to €1.13 in late November 2026, reaching its lowest level against the euro since April 2023.2 The pound also declined 0.5% to $1.3086, hovering near the $1.30 threshold that analysts view as a critical support level.2 Simon Phillips, managing director at No1 Currency, noted the pound remains under pressure amid broader market uncertainty.2

The currency realignment reflects shifting monetary policy expectations, particularly with Federal Reserve leadership transition scheduled for June 2026. Jordan Rochester, analyst at Mizuho Bank, warned the pound could fall below $1.30 as market conditions evolve.2

The British pound had gained 7% against the dollar in 2025, but that momentum reversed in early 2026 as dollar weakness failed to provide sustained support.1 The euro's strength has outpaced sterling gains, creating pressure on UK export competitiveness and cross-border trade dynamics.

Currency volatility has increased across emerging markets as well. The Turkish lira weakened 17% amid a carry trade collapse, while the Swiss franc strengthened as investors sought safe-haven assets.1 These moves highlight the systemic nature of the current currency realignment, with the franc serving as a hedge against broader market instability.

European equity markets showed resilience despite currency turbulence. The Stoxx 600 climbed 0.6% to a record 583.4 points, while Germany's DAX gained 0.9% and France's CAC 40 rose 0.7%.2 The FTSE 100 reached a record high of 9,911, though sterling weakness complicated the outlook for UK importers.2

The dollar's decline has created opportunities for European exporters but challenges for companies with dollar-denominated debt. Market participants are closely watching Fed policy signals as the June 2026 leadership transition approaches, with currency markets pricing in continued volatility through mid-year.

Source documents

Via News is a conduit. We point to the source documents behind this report — we don't replace them. Trace any claim to its source and decide what to trust. How we source

Source Trace Score4 source documents4 with a live linkVerifiability: Strong
  1. [1]News articleUk· November 12, 2025
    Pound hits two-year low against euro as Starmer under fire
  2. [2]News articleYahoo Finance· March 7, 2026
    Ray Dalio says America is facing a ‘debt death spiral’ — but you can protect your portfolio with these 3 assets
  3. [3]News articleYahoo Finance· December 31, 2025
    Stock market today: Dow, S&P 500, Nasdaq post double-digit gains in 2025 as AI trade powers market once again
  4. [4]News articleYahoo Finance· February 17, 2026
    Stock market today: Dow, S&P 500, Nasdaq waver in volatile trading as AI anxiety lingers

In this story · Knowledge Files

LM Salvado
LM Salvado

LM Salvado is an AI possibilist — he takes the risks of AI seriously, and still sees the route through them. Founder of Via News Agency, an AI-native newsroom built on full source-traceability, he tracks how AI is reshaping markets, capital, and labor — the quiet shifts that happen before the headlines catch up.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com